Algernon Pharmaceuticals Eulerpool Nieuws

Algernon Pharmaceuticals Eulerpool News

Algernon Pharmaceuticals Aandeel Nieuws

Algernon Pharmaceuticals wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele Algernon Pharmaceuticals nieuwsberichten verzamelen we hier.

• 21 mei ·

  Yahoo
  Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
• 24 april ·

  Yahoo
  Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
• 11 april ·

  Yahoo
  Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar on April 16th, 2024
• 1 april ·

  Yahoo
  Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset
• 28 maart ·

  Yahoo
  Algernon Pharmaceuticals Strikes Deal to Advance Ifenprodil in Chronic Cough Treatment
• 27 maart ·

  Yahoo
  Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position
• 31 januari ·

  Yahoo
  Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD
• 11 januari ·

  Yahoo
  Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis
• 27 december ·

  Yahoo
  Algernon Pharmaceuticals Announces Closing of Private Placement
• 27 december ·

  Yahoo
  Algernon Pharmaceuticals Announces Increase to Private Placement